Physician

David A. Glaser, MD

According to 2025 Medicare claims, David Glaser, MD (NPI: 1891807137) practices ophthalmology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF ST LOUIS, INC (NPI: 1750581666) and primary practice location at 63376-1667.

Glaser's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 576 traditional Medicare patients, billed 11,250 HCPCS/CPT codes, and received $1,298,953 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 383 prescription claims across 144 beneficiaries totaling $37,489 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 38 records totaling $1,556. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $76,005 to $37,489. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$875K$1.7M2015 Medicare payment: $1,749,208 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,663,661 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,510,342 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,314,932 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,414,271 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,380,096 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,319,984 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,342,348 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,193,861 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,298,953 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201578010,305$1,749,208
20167939,248$1,663,661
20177388,701$1,510,342
20187457,746$1,314,932
20196697,593$1,414,271
20206627,164$1,380,096
20216216,965$1,319,984
20226147,187$1,342,348
202360612,308$1,193,861
202457611,250$1,298,953

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$38K$76K2015 Drug cost: $76,005 (USD; Tot_Drug_Cst)2016 Drug cost: $71,284 (USD; Tot_Drug_Cst)2017 Drug cost: $62,435 (USD; Tot_Drug_Cst)2018 Drug cost: $69,052 (USD; Tot_Drug_Cst)2019 Drug cost: $70,163 (USD; Tot_Drug_Cst)2020 Drug cost: $73,016 (USD; Tot_Drug_Cst)2021 Drug cost: $74,530 (USD; Tot_Drug_Cst)2022 Drug cost: $64,845 (USD; Tot_Drug_Cst)2023 Drug cost: $59,172 (USD; Tot_Drug_Cst)2024 Drug cost: $37,489 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015190558$76,005
2016161477$71,284
2017141412$62,435
2018155463$69,052
2019146415$70,163
2020153412$73,016
2021133400$74,530
2022126360$64,845
2023138391$59,172
2024144383$37,489

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more106106$118
67028Injection of drug into eye158583$93
92014Established patient complete exam of visual system494988$91
92134Imaging of retina5481,166$30
92202Extended exam of the back part of the eye with optic nerve drawing345638$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium23823$7,931
LumiganBimatoprost181,171$7,816
Bromfenac SodiumBromfenac Sodium20663$5,188
Tobramycin-DexamethasoneTobramycin/Dexamethasone792,093$3,467
Prednisolone AcetatePrednisolone Acetate341,780$1,067

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$1,556ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David A. Glaser, MD?

Tedicare shows public-source Medicare data for David A. Glaser, MD (NPI 1891807137), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David A. Glaser, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David A. Glaser, MD?

David A. Glaser, MD is linked to RETINA ASSOCIATES OF ST LOUIS, INC (billing NPI 1750581666) in the available physician profile data.

Does David A. Glaser, MD have Open Payments data?

David A. Glaser, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.